• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Reinforcing Omega-3 Supply Networks

    A Clearer Path to Weight Management: The Ozempic Factor

    Under Pressure: Stress and Mental Health Have Taken Center Stage

    Sustainable Business Development: Principles and Strategies for Progress

    Beauty IO MarketWatch: L’Oréal to Define the Next Era of Beauty Tech in CES 2024 Keynote
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Women's Health Brand O Positiv Launches Essentials Line of Supplements

    Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Xsto Solutions

    BGG World

    CoQ10 Association

    American FlexPack
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Xsto Solutions

    BGG World

    CoQ10 Association

    American FlexPack
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Demystifying the Regulatory Status of CBD

    The hype and the legal issues surrounding cannabinoids need context, and you probably need a lawyer.

    Demystifying the Regulatory Status of CBD
    By Todd Harrison, Venable11.01.18
    With the explosion of interest in products that contain cannabidiol (CBD), now seems like the perfect time to discuss the regulatory status of cannabinoids. This column does not take a position on whether CBD or other cannabinoids should be permitted, from a policy perspective, to be marketed over-the-counter as dietary supplements. Rather, I am posing a series of questions intended to assist companies in determining whether it’s worth the business risk to market these products. So, here we go...

    Question 1: What laws control the use of CBD in dietary supplements?

    Answer: The Control Substance Act (CSA), The Federal Food, Drug, and Cosmetic Act (the Act), the Farm Act of 2014, and finally state laws. Understand, state laws that permit the marketing of CBD products may only pertain to products cultivated, grown. and manufactured within the state pursuant to a permit or license issued by the state. Put another way, a state may prohibit the sale of CBD and hemp extracts that are produced in other states.

    Question 2: Are CBD and other cannabinoids Schedule I controlled substances?

    Answer: The answer to this question turns on the definition of marijuana and whether it is an FDA-approved drug. More specifically, only CBD and cannabinoids that come from the non-resin portion of the plant, including the stalk and the seeds, are exempt from the definition of marijuana and therefore are not Schedule I controlled substances. FDA-approved drugs are Schedule V controlled substances. 

    Question 3: Doesn’t the Farm Act of 2014 essentially de-schedule hemp? 

    Answer: No, it does not. Indeed, the Farm Act of 2014 only permits the growing and propagation of hemp as part of a research project within a state. Even if one could argue that limited commercialization within a state permits the marketing of CBD dietary supplements, it would only apply to that state. For instance, you could not market a CBD dietary supplement that is from the flower or leaf of the plant in the state of Maryland unless the hemp was grown in Maryland pursuant to a permit issued by the state of Maryland. For some reason, this fact remains lost on the industry. Also, if it did allow for the interstate commercialization of hemp and hemp-derived products, the proposed language in the Farm Bill of 2018 de-scheduling hemp would be unnecessary. 

    Question 4: If the CBD in a product comes from the stalk or seed of hemp, can I market it as a dietary supplement or as an ingredient in food?

    Answer: I am not going to be drawn into a debate as to whether it is economically feasible to extract CBD from the stalk or seed of hemp. For our purposes here, we will presume that this statement is true. However, the only practical legal impact is that the product is not subject to the CSA. Similarly, if the source of CBD or other cannabinoids do not come from hemp or other cannabis cultivars, then it is not subject to the CSA.

    However, one must also analyze it under the Federal Food, Drug, and Cosmetic Act. Under Section 201(ff)(3)(B), if the article is marketed as a dietary supplement, it must have been on the marketplace before FDA authorized its investigation as a new drug and substantial clinical trials have been undertaken. This means that CBD and other cannabinoids had to have been marketed prior to GW Pharmaceuticals’ IND for Epidiolex and the start of the clinical trials, which happened in 2007. FDA is on the record in numerous warning letters that it is unaware of CBD’s use in a dietary supplement prior to the IND and institution of clinical trials. 

    Similarly, Section 301(ll) of the Act, does not permit its addition into food if it was not marketed as an article in food prior to the institution of substantial clinical trials. Thus, a Generally Recognized As Safe (GRAS) document produced 11 years after the fact has no legal weight if it cannot be established that CBD was marketed prior to the clinical trials. 

    With that said, Section 301(ll)(2) does allow a company or industry to petition FDA to permit its use in food; so the door is open. The question is whether the industry wants to attempt to petition the agency to permit its marketing in food, which by default would also include dietary supplements. 

    It is important to note the article that was authorized for investigation and subsequent clinical trials is CBD. Cannabidiolic acid (CBDA) and other cannabinoids have not been authorized for investigation or subject to clinical trials. Thus, there is an opening here to market CBDA and the other cannabinoids once the controlled substance issue is straightened out.

    Finally, there are defenses to the preclusion provisions, however, you will need to seek the advice of legal counsel to determine how strong these arguments are, as I do not have the space in this column to go through all the legal arguments. Some of them have merit and pass the laugh test while others are highly suspect. Regardless, this requires you to work through counsel to determine the strength of those arguments. 

    Question 5: Everyone is marketing CBD so it must be legal, right?

    Answer: Law enforcement and regulatory agencies routinely permit the marketing of products that may otherwise be violative through enforcement discretion. Here, I agree, the DEA does not seem very interested and FDA simply needs to make a decision to permit its marketing or enforce. However, while it is high enough on its priority list to merit warning letters, it is not so high (pun intended) to warrant enforcement action, but that is simply reading the tea leaves. 

    With that said, here is something that no one talks about and people refuse to deal with: domestic credit card processors will not knowingly process for companies that are selling CBD because of concerns regarding its controlled substance status. Thus, many of the companies that are processing are not informing the processor that it is for CBD products, which may itself create an entirely different set of legal issues; or they are using expensive offshore processors, which come at a premium. Of course, this is another issue that is simply not discussed but must be factored into any decision to market CBD products.

    Question 6: When the Farm Bill of 2018 is passed won’t it take care of everything?

    Answer: By the time this column publishes, the Farm Bill of 2018 may have passed and it may include language about hemp. However, the Farm Bill of 2018 only de-schedules hemp and products derived from hemp; it does not impact the FFDCA analysis because the language (as it stands as of this writing) makes it clear that nothing within the bill would modify or preempt the FFDCA.

    Question 7: What about topical products?

    Answer: Presuming you can overcome the CSA, the preclusion provisions of the FFDCA do not apply to topical cosmetic products as along as impermissible drug claims are not being made. 
    I hope this column at least places the issues surrounding CBD and cannabinoids in the appropriate context. I am hopeful that in the near future the CSA issue will be placed to rest with the Farm Bill of 2018. I am also hopeful that at some point someone with strong safety data comes forward to request permission from FDA to sell CBD in foods and dietary supplements, as there is a reason we have an endocannabinoid system. Providing it with nutritional support would have significant health benefits completely unrelated to treating rare epileptic seizures.

    As I have stated so many times in columns and speeches, we need to stop treating everything as a binary choice between being diseased or being healthy. In fact, “healthy” encompasses a wide spectrum. Indeed, osteoarthritis, while classified as a disease, is in fact normal wear and tear that we all experience. Yet people are denied access to products that may help them and instead are prescribed opioids; and we have seen what that has wrought on society.

    Companies in the natural product/dietary supplement industry often wonder why regulators don’t seem to trust the industry. However, rushing ingredients into the market on questionable legal theories without following the regulatory process is one reason for this distrust. I understand frustration when it comes to claims, but cavalier attitudes toward regulatory procedures of ingredients pose a more long-term threat to the industry.

    Still, it’s challenging when FDA seems more concerned with “disease” claims related to supporting fertility and age-related joint pain rather than enforcing the dietary ingredient provisions of the Act. But that is simply my take about ingredients in general, and not on CBD in particular.


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling, and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Functional Food
    • ftc
    • GRAS
    • Osteoarthritis
    Suggested For You
    Charlotte’s Web COO Jared Stanley Discusses the State of Play for CBD Charlotte’s Web COO Jared Stanley Discusses the State of Play for CBD
    CV Sciences Launches Reserve Sleep Gummies CV Sciences Launches Reserve Sleep Gummies
    Novel Creations in Wellness Supplements for Beauty Inside Out Novel Creations in Wellness Supplements for Beauty Inside Out
    Mind The Gaps: Supporting Voices of BIPOC-Owned Wellness Businesses Mind The Gaps: Supporting Voices of BIPOC-Owned Wellness Businesses
    AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD
    Supplement Orgs Respond to Congressional Request for Information on CBD Supplement Orgs Respond to Congressional Request for Information on CBD
    Stakeholders Demand Action on CBD at House Subcommittee Hearing Stakeholders Demand Action on CBD at House Subcommittee Hearing
    ICYMI: Top Content from July 2023 on NutraceuticalsWorld.com ICYMI: Top Content from July 2023 on NutraceuticalsWorld.com
    FDA Rejects Request to Hold Public Hearing on NMN FDA Rejects Request to Hold Public Hearing on NMN
    Water-Soluble CBD has Immunomodulatory Effects Water-Soluble CBD has Immunomodulatory Effects
    Charlotte’s Web Expands with ReCreate Line of Sports Nutrition CBD Products Charlotte’s Web Expands with ReCreate Line of Sports Nutrition CBD Products
    CBD Shown to Confer Sleep Benefits Similar to Melatonin CBD Shown to Confer Sleep Benefits Similar to Melatonin
    Herbal and Botanical Supplements Continue to Outpace Broader Market Amid Economic Uncertainty Herbal and Botanical Supplements Continue to Outpace Broader Market Amid Economic Uncertainty
    A Flavor-Forward Sports Nutrition Market Gains Strength A Flavor-Forward Sports Nutrition Market Gains Strength
    Canomiks CEO and Co-Founder on Developing Personalized Nutrition Formulations Canomiks CEO and Co-Founder on Developing Personalized Nutrition Formulations

    Related Columns

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      Charlotte’s Web COO Jared Stanley Discusses the State of Play for CBD

      Charlotte’s Web COO Jared Stanley Discusses the State of Play for CBD

      Executive offers updates on the company’s advocacy for federal regulation, its partnership with MLB, market challenges, and more.
      By Sheldon Baker 09.28.23

    • Breaking News | Herbs & Botanicals | Mood Health & Sleep | Products
      CV Sciences Launches Reserve Sleep Gummies

      CV Sciences Launches Reserve Sleep Gummies

      The full-spectrum gummies contain a blend of CBD, THC, CBN, and melatonin.
      09.08.23

    • Contract Manufacturing | Cosmeceuticals / Nutricosmetics | Delivery & Dosage Technologies | Dietary Supplements | Healthy Aging | Natural/Organic | Skin Health
      Novel Creations in Wellness Supplements for Beauty Inside Out

      Novel Creations in Wellness Supplements for Beauty Inside Out

      Beauty is an inside job. Consumers can help their outsides shine with a daily dose of vitamins and antioxidants.
      By Melissa Meisel, Senior Editor, Happi 08.31.23


    • Contract Manufacturing | Cosmeceuticals / Nutricosmetics | Healthcare Trends | Healthy Aging | Men's Health | Skin Health | Women's Health
      Mind The Gaps: Supporting Voices of BIPOC-Owned Wellness Businesses

      Mind The Gaps: Supporting Voices of BIPOC-Owned Wellness Businesses

      For BIPOC entrepreneurs and small businesses, there are more grant programs and incubators offering access to critical funding.
      By Christine Esposito, Managing Editor, Happi 08.31.23

    • Breaking News | Herbs & Botanicals | Quality & Safety | Regulations | Regulatory News
      AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD

      AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD

      The three organizations jointly outlined why existing regulatory frameworks are sufficient to regulate CBD-containing dietary supplements.
      08.23.23

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Todd Spear Joins Protein Research As VP Of Sales And Marketing
    • Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    • New Technology Converts Sugar In Juice To Fiber
    Breaking News
    • D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    • Natrol Launches First Non-Melatonin Sleep Supplement
    • Metagenics Releases Consumer Survey on Menopausal Support Supplement
    • Culturelle Probiotics Launches Women’s Health Awareness Campaign
    • Women's Health Brand O Positiv Launches Essentials Line of Supplements
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • A Clearer Path to Weight Management: The Ozempic Factor
    • Under Pressure: Stress and Mental Health Have Taken Center Stage
    • Sustainable Business Development: Principles and Strategies for Progress
    • BIOHM Health Targets ‘Digestive Plaque’ with Probiotic, Fungus, and Enzyme Formula
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    BASF Donates $5,000 to High School STEAM Education Programs in Chattanooga Area
    Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
    California Sports Surfaces Celebrates 70 Years
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 30
    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    ScentAir Debuts Room Sprays & More
    African Pride Launches On-Campus Activations
    Sharper Image Debuts Revel Hair Tools
    Happi

    Latest Breaking News From Happi

    Is Dr. Barbara Sturm Skincare Considering a Sale?
    YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
    Christian Siriano Appointed Olay’s First Chief Drop Officer
    Ink World

    Latest Breaking News From Ink World

    MicroDynamics, All Printing Resources Partner to Represent Veritas
    Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
    Siegwerk’s Climate Targets Validated by SBTi
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI's LLT grows, Labelexpo Europe details big numbers and more
    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Thomas Receives INDA Lifetime Technical Service Award, ExxonMobil Works with JL Goor
    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 30
    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login